Inflammatory Signalings Involved in Airway and Pulmonary Diseases
In respiratory diseases, there is an increased expression of multiple inflammatory proteins in the respiratory tract, including cytokines, chemokines, and adhesion molecules. Chemokines have been shown to regulate inflammation and immune cell differentiation. Moreover, many of the known inflammatory...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/791231 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832552330624499712 |
---|---|
author | I-Ta Lee Chuen-Mao Yang |
author_facet | I-Ta Lee Chuen-Mao Yang |
author_sort | I-Ta Lee |
collection | DOAJ |
description | In respiratory diseases, there is an increased expression of multiple inflammatory proteins in the respiratory tract, including cytokines, chemokines, and adhesion molecules. Chemokines have been shown to regulate inflammation and immune cell differentiation. Moreover, many of the known inflammatory target proteins, such as matrix metalloproteinase-9 (MMP-9), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), cyclooxygenase-2 (COX-2), and cytosolic phospholipase A2 (cPLA2), are associated with airway and lung inflammation in response to various stimuli. Injuriously environmental stimuli can access the lung through either the airways or the pulmonary and systemic circulations. The time course and intensity of responses by resident and circulating cells may be regulated by various inflammatory signalings, including Src family kinases (SFKs), protein kinase C (PKC), growth factor tyrosine kinase receptors, nicotinamide adenine dinucleotide phosphate (NADPH)/reactive oxygen species (ROS), PI3K/Akt, MAPKs, nuclear factor-kappa B (NF-κB), activator protein-1 (AP-1), and other signaling molecules. These signaling molecules regulate both key inflammatory signaling transduction pathways and target proteins involved in airway and lung inflammation. Here, we discuss the mechanisms involved in the expression of inflammatory target proteins associated with the respiratory diseases. Knowledge of the mechanisms of inflammation regulation could lead to the pharmacological manipulation of anti-inflammatory drugs in the respiratory diseases. |
format | Article |
id | doaj-art-e0c0425983914486959197fe1a42e1e6 |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2013-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-e0c0425983914486959197fe1a42e1e62025-02-03T05:59:05ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/791231791231Inflammatory Signalings Involved in Airway and Pulmonary DiseasesI-Ta Lee0Chuen-Mao Yang1Department of Anesthetics, Chang Gung Memorial Hospital at Linkuo and Chang Gung University, Kwei-San, Tao-Yuan 33302, TaiwanDepartment of Physiology and Pharmacology and Health Aging Research Center, College of Medicine, Chang Gung University Kwei-San, Tao-Yuan 33302, TaiwanIn respiratory diseases, there is an increased expression of multiple inflammatory proteins in the respiratory tract, including cytokines, chemokines, and adhesion molecules. Chemokines have been shown to regulate inflammation and immune cell differentiation. Moreover, many of the known inflammatory target proteins, such as matrix metalloproteinase-9 (MMP-9), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), cyclooxygenase-2 (COX-2), and cytosolic phospholipase A2 (cPLA2), are associated with airway and lung inflammation in response to various stimuli. Injuriously environmental stimuli can access the lung through either the airways or the pulmonary and systemic circulations. The time course and intensity of responses by resident and circulating cells may be regulated by various inflammatory signalings, including Src family kinases (SFKs), protein kinase C (PKC), growth factor tyrosine kinase receptors, nicotinamide adenine dinucleotide phosphate (NADPH)/reactive oxygen species (ROS), PI3K/Akt, MAPKs, nuclear factor-kappa B (NF-κB), activator protein-1 (AP-1), and other signaling molecules. These signaling molecules regulate both key inflammatory signaling transduction pathways and target proteins involved in airway and lung inflammation. Here, we discuss the mechanisms involved in the expression of inflammatory target proteins associated with the respiratory diseases. Knowledge of the mechanisms of inflammation regulation could lead to the pharmacological manipulation of anti-inflammatory drugs in the respiratory diseases.http://dx.doi.org/10.1155/2013/791231 |
spellingShingle | I-Ta Lee Chuen-Mao Yang Inflammatory Signalings Involved in Airway and Pulmonary Diseases Mediators of Inflammation |
title | Inflammatory Signalings Involved in Airway and Pulmonary Diseases |
title_full | Inflammatory Signalings Involved in Airway and Pulmonary Diseases |
title_fullStr | Inflammatory Signalings Involved in Airway and Pulmonary Diseases |
title_full_unstemmed | Inflammatory Signalings Involved in Airway and Pulmonary Diseases |
title_short | Inflammatory Signalings Involved in Airway and Pulmonary Diseases |
title_sort | inflammatory signalings involved in airway and pulmonary diseases |
url | http://dx.doi.org/10.1155/2013/791231 |
work_keys_str_mv | AT italee inflammatorysignalingsinvolvedinairwayandpulmonarydiseases AT chuenmaoyang inflammatorysignalingsinvolvedinairwayandpulmonarydiseases |